Evidence map›Paper›PMID 34036197›Full record

ArticleHeliyon2021

Synthesis and evaluation of the

Roger Espinosa, Sara Robledo, Camilo Guzmán, Natalia Arbeláez, Lina Yepes, Gílmar Santafé, Alex Sáez

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Roger EspinosaIDEFARMA - Department of Regency and Pharmacy, University of Córdoba, Montería, Colombia.
Sara RobledoPECET - Faculty of Medicine, University of Antioquia, Medellin, Colombia.
Camilo GuzmánIDEFARMA - Department of Regency and Pharmacy, University of Córdoba, Montería, Colombia.
Natalia ArbeláezPECET - Faculty of Medicine, University of Antioquia, Medellin, Colombia.
Lina YepesPECET - Faculty of Medicine, University of Antioquia, Medellin, Colombia.
Gílmar SantaféDepartment of Chemistry, University of Córdoba, Montería, Colombia.
Alex SáezDepartment of Biological Sciences, EAFIT University, Medellin, Colombia.
Universidad de Antioquia · COUniversity of Córdoba · COUniversidad EAFIT · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we report the synthesis and evaluation of

Indexed as

2-styrylquinolinesAntiprotozoal activityAntitrypanosomal activityChagas diseaseTrypanosoma cruzi

Identifiers

PMID34036197
PMCPMC8134988
OpenAlexW3161001365

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.